BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16311241)

  • 1. Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation.
    Wagner TM; Mullally JE; Fitzpatrick FA
    J Biol Chem; 2006 Feb; 281(5):2598-604. PubMed ID: 16311241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational modification of serine/threonine kinase LKB1 via Adduction of the Reactive Lipid Species 4-Hydroxy-trans-2-nonenal (HNE) at lysine residue 97 directly inhibits kinase activity.
    Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
    J Biol Chem; 2012 Dec; 287(50):42400-6. PubMed ID: 23086944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway.
    Mullally JE; Moos PJ; Edes K; Fitzpatrick FA
    J Biol Chem; 2001 Aug; 276(32):30366-73. PubMed ID: 11390388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
    Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
    Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
    Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
    J Biol; 2003; 2(4):28. PubMed ID: 14511394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LKB1 kinase: master and commander of metabolism and polarity.
    Spicer J; Ashworth A
    Curr Biol; 2004 May; 14(10):R383-5. PubMed ID: 15186763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-Δ
    Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
    Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages.
    Musiek ES; Gao L; Milne GL; Han W; Everhart MB; Wang D; Backlund MG; DuBois RN; Zanoni G; Vidari G; Blackwell TS; Morrow JD
    J Biol Chem; 2005 Oct; 280(42):35562-70. PubMed ID: 16100121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
    Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
    Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
    J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress.
    Kondo M; Oya-Ito T; Kumagai T; Osawa T; Uchida K
    J Biol Chem; 2001 Apr; 276(15):12076-83. PubMed ID: 11278531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.
    Straus DS; Glass CK
    Med Res Rev; 2001 May; 21(3):185-210. PubMed ID: 11301410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lkb1 regulation of skeletal muscle development, metabolism and muscle progenitor cell homeostasis.
    Shan T; Xu Z; Liu J; Wu W; Wang Y
    J Cell Physiol; 2017 Oct; 232(10):2653-2656. PubMed ID: 28067405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid-protein interactomes.
    Stamatakis K; Pérez-Sala D
    Ann N Y Acad Sci; 2006 Dec; 1091():548-70. PubMed ID: 17341644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase.
    Ferrarone JR; Thomas J; Unni AM; Zheng Y; Nagiec MJ; Gardner EE; Mashadova O; Li K; Koundouros N; Montalbano A; Mustafa M; Cantley LC; Blenis J; Sanjana NE; Varmus H
    Proc Natl Acad Sci U S A; 2024 May; 121(21):e2403685121. PubMed ID: 38743625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural product antroalbol H promotes phosphorylation of liver kinase B1 (LKB1) at threonine 189 and thereby enhances cellular glucose uptake.
    Wang F; Yang X; Lu Y; Li Z; Xu Y; Hu J; Liu J; Xiong W
    J Biol Chem; 2019 Jul; 294(27):10415-10427. PubMed ID: 31113861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LKB1/AMPK polarity pathway.
    Mirouse V; Billaud M
    FEBS Lett; 2011 Apr; 585(7):981-5. PubMed ID: 21185289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
    Upadhyay S; Liu C; Chatterjee A; Hoque MO; Kim MS; Engles J; Westra W; Trink B; Ratovitski E; Sidransky D
    Cancer Res; 2006 Aug; 66(16):7870-9. PubMed ID: 16912160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LKB1 Represses ATOH1 via PDK4 and Energy Metabolism and Regulates Intestinal Stem Cell Fate.
    Gao Y; Yan Y; Tripathi S; Pentinmikko N; Amaral A; Päivinen P; Domènech-Moreno E; Andersson S; Wong IPL; Clevers H; Katajisto P; Mäkelä TP
    Gastroenterology; 2020 Apr; 158(5):1389-1401.e10. PubMed ID: 31930988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.